New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S133

Introduced
1/9/24  

Caption

Limits rescheduling, cancellation, and no-show fees providers of health care services may charge in certain instances.

Impact

Under S133, healthcare providers will not be able to charge patients for cancellations made more than 24 hours prior to an appointment. In cases where cancellations or rescheduling occur within less than 24 hours, providers may only charge a capped fee of $25, provided specific conditions are met, including prior notification about potential fees and a record of previous late cancellations by the same patient. This provision is designed to ensure fairness while preventing excessive financial penalties driven by unforeseen circumstances.

Summary

Senate Bill 133 (S133) seeks to regulate the fees charged by healthcare providers concerning appointment cancellations and rescheduling. The bill explicitly aims to limit the fees providers can impose on patients for rescheduling or canceling appointments, particularly emphasizing cases where patients give over 24 hours' notice. By creating a clear framework, the bill envisions reducing the financial burden on patients while maintaining a degree of accountability for no-shows and late cancellations.

Contention

The bill's proponents argue that S133 is necessary to protect patients from undue financial penalties, especially for unexpected life events that compel them to cancel or reschedule appointments. However, some critics may raise concerns about the potential financial impact on healthcare providers, particularly smaller practices that could rely on such fees to manage their scheduling and operational costs. This balance between patient protection and the financial viability of healthcare providers is likely to be a focal point of debate surrounding the bill.

Companion Bills

NJ S2099

Carry Over Limits rescheduling, cancellation, and no-show fees providers of health care services may charge in certain instances.

Previously Filed As

NJ S2485

Limits rescheduling, cancellation, and no-show fees providers of health care services may charge in certain instances.

NJ HB306

Prohibit Certain Health Care Facility Fees

NJ S1076

Requires adult day health care facilities to establish hybrid model for provision of adult day health care services under certain circumstances.

NJ HB760

Provides relative to unauthorized fees charged by healthcare providers for certain treatments

NJ HF1312

Facility fees for nonemergency services provided at provider-based clinics prohibited, facility fees for certain health care services prohibited, and report required.

NJ S3140

Limits fees charged to patients and authorized third parties for copies of medical and billing records.

NJ S08039

Prohibits hospitals, health systems, and health care providers from charging facility fees that are not covered by the patient's health insurance carrier.

NJ A455

Requires cancellation option for any subscription service and establishes certain standards pertaining to use of negative option features.

NJ HB2683

Allowing healthcare providers to charge fees to furnish a patient's healthcare records and providing for the disclosure of a deceased patient's healthcare records to certain individuals.

NJ A3403

Limits increases to certain recurring fees charged to residential tenant.

Similar Bills

NJ A624

Reschedules June 2025 primary election date; provides for adjustment of date on which primary elections will be held if date coincides with period of religious observance.

TX HB4813

Relating to the scheduling of certain controlled substances in response to certain actions by the United States Food and Drug Administration with respect to those substances.

CA AB1778

Controlled substances: testosterone.

NJ S2485

Limits rescheduling, cancellation, and no-show fees providers of health care services may charge in certain instances.

SC H3538

Controlled Substances

IL SB4202

CONTROLLED SUB-SCHEDULING

TX SB2997

Relating to the scheduling of certain controlled substances in response to certain actions by the United States Food and Drug Administration.

CO SB031

Use of Prescription Product with Controlled Substance